Adenosine transport blockade restores attenuated cardioprotective effects of adenosine preconditioning in the isolated diabetic rat heart: Potential crosstalk with opioid receptors

Cardiovascular Toxicology

Volumn 13, Issue 1, 2013, Pages 22-32

  Sharma, Nidhi Krishan ^a   Mahadevan, Nanjaian ^a   Balakumar, Pitchai ^a  

^a Rajendra Institute of Technology and Sciences   (India)

Author keywords

Adenosine preconditioning; Adenosine transport blockade; Diabetes mellitus; Myocardial I R injury; Opioid receptor activation

Indexed keywords

ADENOSINE; CHOLESTEROL; CREATINE KINASE MB; DIPYRIDAMOLE; GLUTATHIONE; LACTATE DEHYDROGENASE; NALOXONE; OPIATE RECEPTOR; STREPTOZOCIN; THIOBARBITURIC ACID REACTIVE SUBSTANCE;

ANIMAL EXPERIMENT; ANIMAL MODEL; ANIMAL TISSUE; ARTICLE; CHOLESTEROL BLOOD LEVEL; CONTROLLED STUDY; CORONARY ARTERY BLOOD FLOW; DIABETIC CARDIOMYOPATHY; ENZYME RELEASE; FEMALE; FLOW RATE; HEART INFARCTION SIZE; HEART INJURY; HEART PROTECTION; ISCHEMIC PRECONDITIONING; ISOLATED HEART; MALE; NONHUMAN; OXIDATIVE STRESS; PRIORITY JOURNAL; RAT; REPERFUSION INJURY; SIGNAL TRANSDUCTION; STREPTOZOCIN DIABETES;

ADENOSINE; ANIMALS; CARDIOTONIC AGENTS; DIABETES MELLITUS, EXPERIMENTAL; DIPYRIDAMOLE; FEMALE; HEART; ISCHEMIC PRECONDITIONING, MYOCARDIAL; MALE; PROTEIN TRANSPORT; RATS; RATS, WISTAR; RECEPTOR CROSS-TALK; RECEPTORS, OPIOID;

RATTUS;

EID: 84872520167     PISSN: 15307905     EISSN: 15590259     Source Type: Journal    
DOI: 10.1007/s12012-012-9182-y     Document Type: Article

References (58)

1. Kalra, B. S.; & Roy, V. (2012). Efficacy of metabolic modulators in ischemic heart disease: An overview. Journal of Clinical Pharmacology, 52, 292-305.
2. Alipour, N.; Wong, N. D.; & Malik, S. (2012). Diagnosis of coronary artery disease in persons with diabetes mellitus. Current Diabetes Reports, 12, 286-293.
3. Yin, X.; Zheng, Y.; Zhai, X.; Zhao, X.; & Cai, L. (2012). Diabetic inhibition of preconditioning- and- postconditioning-mediated myocardial protection against ischemia/reperfusion injury. Experimental Diabetes Research, 2012, 198048.
4. Ferrari, R.; Ceconi, C.; Curello, S.; Alfieri, O.; & Visioli, O. (1993). Myocardial damage during ischaemia and reperfusion. European Heart Journal, 14, 25-30. (Pubitemid 24040071)
5. Lutz, J.; Thürmel, K.; & Heemann, U. (2010). Anti-inflammatory treatment strategies for ischemia/reperfusion injury in transplantation. Journal of Inflammation, 10, 7-27.
6. Balakumar, P.; & Babbar, L. (2012). Preconditioning the hyperlipidemic myocardium: Fact or fantasy? Cellular Signalling, 24, 589-595.
7. Hausenloy, D. J.; & Yellon, D. M. (2004). New directions for protecting the heart against ischaemia-reperfusion injury: Targeting the Reperfusion Injury Salvage Kinase (RISK)-pathway. Cardiovascular Research, 61, 448-460. (Pubitemid 38210151)
8. Balakumar, P.; & Sharma, N. K. (2012). Healing the diabetic heart: Does myocardial preconditioning work? Cellular Signalling, 24, 53-59.
9. Balakumar, P.; Rohilla, A.; & Singh, M. (2008). Pre-conditioning and postconditioning to limit ischemia-reperfusion-induced myocardial injury: What could be the next footstep? Pharmacological Research, 57, 403-412.
10. Murry, C. E.; Jennings, R. B.; & Reimer, K. A. (1986). Preconditioning with ischemia: A delay of lethal cell injury in ischemic myocardium. Circulation, 74, 1124-1136. (Pubitemid 17174962)
11. Downey, J. M.; Davis, A. M.; & Cohen, M. V. (2007). Signaling pathways in ischemic preconditioning. Heart Failure Reviews, 12, 181-188. (Pubitemid 350176691)
12. Cohen, M. V.; & Downey, J. M. (2008). Adenosine: Trigger and mediator of cardioprotection. Basic Research in Cardiology, 103, 203-215.
13. Boutros, A.; & Wang, J. (1995). Ischemic preconditioning, adenosine and bethanechol protect spontaneously hypertensive isolated rat hearts. Journal of Pharmacology and Experimental Therapeutics, 275, 1148-1156. (Pubitemid 26129915)
14. Cordeiro, J. M.; Ferrier, G. R.; & Howlett, S. E. (1995). Effects of adenosine in simulated ischemia and reperfusion in guinea pig ventricular myocytes. American Journal of Physiology, 269, H121-H129.
15. Lasley, R. D.; & Mentzer, R. M.; Jr. (1995). Protective effects of adenosine in the reversibly injured heart. Annals of Thoracic Surgery, 60, 843-846.
16. Lee, H. T.; LaFaro, R. J.; & Reed, G. E. (1995). Pretreatment of human myocardium with adenosine during open heart surgery. Journal of Cardiac Surgery, 10, 665-676.
17. Vinten-Johansen, J.; Zhao, Z. Q.; & Sato, H. (1995). Reduction in surgical ischemic-reperfusion injury with adenosine and nitric oxide therapy. Annals of Thoracic Surgery, 60, 852-857.
18. Wasir, H.; Bhan, A.; Choudhary, S. K.; Sharma, R.; Chauhan, S.; & Venugopal, P. (2001). Pretreatment of human myocardium with adenosine. European Journal of Cardio-Thoracic Surgery, 19, 41-46. (Pubitemid 32036952)
19. Germack, R.; & Dickenson, J. M. (2005). Adenosine triggers preconditioning through MEK/ERK1/2 signalling pathway during hypoxia/reoxygenation in neonatal rat cardiomyocytes. Journal of Molecular and Cellular Cardiology, 39, 429-442. (Pubitemid 41133729)
20. Ban, K.; Cooper, A. J.; Samuel, S.; Bhatti, A.; Patel, M.; Izumo, S.; et al. (2008). Phosphatidylinositol 3-kinase gamma is a critical mediator of myocardial ischemic and adenosine-mediated preconditioning. Circulation Research, 103, 643-653.
21. Ye, F.; Fang, W.; Wang, F.; Hua, Z. C.; Wang, Z.; & Yang, X. (2011). Evaluation of adenosine preconditioning with 99mTc-His10-annexin V in a porcine model of myocardium ischemia and reperfusion injury: Preliminary study. Nuclear Medicine and Biology, 38, 567-574.
22. Peart, J. N.; & Gross, G. J. (2003). Adenosine and opioid receptor-mediated cardioprotection in the rat: Evidence for cross-talk between receptors. American Journal of Physiology. Heart and Circulatory Physiology, 285, H81-H89.
23. Balakumar, P.; Singh, H.; Singh, M.; & Anand-Srivastava, M. B. (2009). The impairment of preconditioning-mediated cardioprotection in pathological conditions. Pharmacological Research, 60, 18-23.
24. Tosaki, A.; Engelman, D. T.; Engelman, R. M.; & Das, D. K. (1996). The evolution of diabetic response to ischemia/reperfusion and preconditioning in isolated working rat hearts. Cardiovascular Research, 31, 526-536. (Pubitemid 26140063)
25. Lu, R.; Hu, C. P.; Peng, J.; Deng, H. W.; & Li, Y. J. (2001). Role of calcitonin gene-related peptide in ischaemic preconditioning in diabetic rat hearts. Clinical and Experimental Pharmacology and Physiology, 28, 392-396. (Pubitemid 32538905)
26. Shi-ting, W.; Mang-hua, X.; Wen-ting, C.; Feng-hou, G.; & Zhu-ying, G. (2011). Study on tolerance to ischemia-reperfusion injury and protection of ischemic preconditioning of type 1 diabetes rat heart. Biomedical Aging Pathology, 1, 56-60.
27. Podgorska, M.; Kocbuch, K.; Grden, M.; Szutowicz, A.; & Pawelczyk, T. (2006). Reduced ability to release adenosine by diabetic rat cardiac fibroblasts due to altered expression of nucleoside transporters. Journal of Physiology, 576, 179-189. (Pubitemid 44426228)
28. Podgorska, M.; Kocbuch, K.; Grden, M.; Szutowicz, A.; & Pawelczyk, T. (2006). Prevalence of unidirectional Na + -dependent adenosine transport and altered potential for adenosine generation in diabetic cardiac myocytes. Basic Research in Cardiology, 101, 214-222.
29. Langendorff, O. (1895). Untersuchungen am uberlebenden Saugethierherzen. Pflugers Archiv, 61, 291-332.
30. Parikh, V.; & Singh, M. (1999). Possible role of adrenergic component and cardiac mast cell degranulation in preconditioning-induced cardioprotection. Pharmacological Research, 40, 129-137. (Pubitemid 29378092)
31. Fishbein, M. C.; Meerbaum, S.; Rit, J.; Lando, U.; Kanmatsuse, K.; Mercier, J. C.; et al. (1981). Early phase acute myocardial infarct size quantification: Validation of the triphenyl tetrazolium chloride tissue enzyme staining technique. American Heart Journal, 101, 593-600. (Pubitemid 11120523)
32. Chopra, K.; Singh, M.; Kaul, N.; Andrabi, K. I.; & Ganguly, N. K. (1992). Decrease of myocardial infarct size with desferrioxamine: Possible role of oxygen free radicals in its ameliorative effect. Molecular and Cellular Biochemistry, 113, 71-76.
33. Ohkawa, H.; Ohishi, N.; & Ya, K. (1979). Assay for lipid peroxides in animal tissues by thiobarbituric acid reaction. Analytical Biochemistry, 95, 351-358. (Pubitemid 9194347)
34. Ma, F. X.; Liu, L. Y.; & Xiong, X. M. (2003). Protective effects of lovastatin on vascular endothelium injured by low density lipoprotein. Acta Pharmacologica Sinica, 24, 1027-1032.
35. Ellman, G. L. (1959). Tissue sulfhydryl groups. Archives of Biochemistry and Biophysics, 82, 70-77.
36. Boyne, A. F.; & Ellman, G. L. (1972). A methodology for analysis of tissue sulfhydryl components. Analytical Biochemistry, 46, 639-653.
37. Hausenloy, D. J.; Boston-Griffiths, E.; & Yellon, D. M. (2012). Cardioprotection during cardiac surgery. Cardiovascular Research, 94, 253-265.
38. Yellon, D. M.; Alkhulaifi, A. M.; & Pugsley, W. B. (1993). Preconditioning the human myocardium. Lancet, 342, 276-277. (Pubitemid 23224422)
39. Alkhulaifi, A. M. (1997). Preconditioning the human heart. Annals of the Royal College of Surgeons of England, 79, 49-54. (Pubitemid 27055519)
40. Jenkins, D. P.; Pugsley, W. B.; Alkhulaifi, A. M.; Kemp, M.; Hooper, J.; & Yellon, D. M. (1997). Ischaemic preconditioning reduces troponin T release in patients undergoing coronary artery bypass surgery. Heart, 77, 314-318. (Pubitemid 27208169)
41. Churchill, E. N.; Ferreira, J. C.; Brum, P. C.; Szweda, L. I.; & Mochly-Rosen, D. (2010). Ischaemic preconditioning improves proteasomal activity and increases the degradation of deltaPKC during reperfusion. Cardiovascular Research, 85, 385-394.
42. Ghosh, S.; Standen, N. B.; & Galiñianes, M. (2001). Failure to precondition pathological human myocardium. Journal of the American College of Cardiology, 37, 711-718. (Pubitemid 32202434)
43. Willems, L.; Ashton, K. J.; & Headrick, J. P. (2005). Adenosine-mediated cardioprotection in the aging myocardium. Cardiovascular Research, 66, 245-255. (Pubitemid 40471039)
44. Kaur, H.; Parikh, V.; Sharma, A.; & Singh, M. (1997). Effect of amiloride A Na +/H + exchange inhibitor on cardioprotective effect of ischaemic preconditioning: Possible involvement of resident cardiac mast cells. Pharmacological Research, 36, 95-102. (Pubitemid 27460405)
45. Sharma, A.; & Singh, M. (2000). Possible mechanism of cardioprotective effect of angiotensin preconditioning in isolated rat heart. European Journal of Pharmacology, 406, 85-92.
46. Balakumar, P.; Rohilla, A.; Singh, G.; Singh, K.; & Singh, M. (2009). Modulation of cardioprotective effect of ischemic pre- and postconditioning in the hyperhomocysteinemic rat heart. Methods and Findings in Experimental and Clinical Pharmacology, 31, 71-79.
47. Filippo, C. D.; Perretti, M.; Rossi, F.; Ferraraccio, F.; Motterlini, R.; & D'Amico, M. (2012). Acute myocardial infarction in streptozotocin-induced hyperglycaemic rats: Protection by a carbon monoxide-releasing molecule (CORM-3). Naunyn Schmiedebergs Arch Pharmacol, 385, 137-144.
48. Banerjee, S. K.; Dinda, A. K.; Manchanda, S. C.; & Maulik, S. K. (2002). Chronic garlic administration protects rat heart against oxidative stress induced by ischemic reperfusion injury. BMC Pharmacology, 2, 16.
49. Pálfi, A.; Tóth, A.; Kulcsár, G.; Hantó, K.; Deres, P.; Bartha, E.; et al. (2005). The role of Akt and mitogen-activated protein kinase systems in the protective effect of poly(ADP-ribose) polymerase inhibition in Langendorff perfused and in isoproterenol-damaged rat hearts. Journal of Pharmacology and Experimental Therapeutics, 315, 273-282. (Pubitemid 41380521)
50. Singh, A. P.; Singh, M.; & Balakumar, P. (2008). Effect of mast cell stabilizers in hyperhomocysteinemia-induced cardiac hypertrophy in rats. Journal of Cardiovascular Pharmacology, 51, 596-604.
51. Guideri, F.; Ferber, D.; Galgano, G.; Frigerio, C.; De Giorgi, L.; Laghi Pasini, F.; et al. (1994). Calcium infusion induces myocardial ischaemia in patients with coronary artery disease by a mechanism possibly adenosine mediated. European Heart Journal, 15, 1158-1163. (Pubitemid 124005602)
52. Chung, E. S.; Perlini, S.; Aurigemma, G. P.; Fenton, R. A.; Dobson, J. G. Jr, & Meyer, T. E. (1998). Effects of chronic adenosine uptake blockade on adrenergic responsiveness and left ventricular chamber function in pressure overload hypertrophy in the rat. Journal of Hypertension, 16, 1813-1822. (Pubitemid 28548521)
53. Kalsi, K. K.; Smolenski, R. T.; & Yacoub, M. H. (1998). Effects of nucleoside transport inhibitors and adenine/ribose supply on ATP concentration and adenosine production in cardiac myocytes. Molecular and Cellular Biochemistry, 180, 193-199. (Pubitemid 28118819)
54. Asakura, M.; Asanuma, H.; Kim, J.; Liao, Y.; Nakamaru, K.; Fujita, M.; et al. (2007). Impact of adenosine receptor signaling and metabolism on pathophysiology in patients with chronic heart failure. Hypertension Research, 30, 781-787. (Pubitemid 47578239)
55. Gross, G. J. (2003). Role of opioids in acute and delayed preconditioning. Journal of Molecular and Cellular Cardiology, 35, 709-718. (Pubitemid 36773582)
56. Heidland, U. E.; Heintzen, M. P.; Michel, C. J.; & Strauer, B. E. (2000). Adjunctive intracoronary dipyridamole in the interventional treatment of small coronary arteries: A prospectively randomized trial. American Heart Journal, 139, 1039-1045. (Pubitemid 30390333)
57. Slater, T. F. (1984). Overview of methods used for detecting lipid peroxidation. Methods in Enzymology, 105, 283-293. (Pubitemid 14165388)
58. Jiang, T. X.; Reid, W. D.; & Road, J. D. (2001). Free radical scavengers and diaphragm injury following inspiratory resistive loading. American Journal of Respiratory and Critical Care Medicine, 164, 1288-1294. (Pubitemid 33052265)